Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.310
+0.090 (4.05%)
At close: Dec 20, 2024, 3:51 PM
2.390
+0.080 (3.46%)
After-hours: Dec 20, 2024, 7:56 PM EST

Stereotaxis Market Cap

Stereotaxis has a market cap or net worth of $199.11 million as of December 20, 2024. Its market cap has increased by 30.91% in one year.

Market Cap
199.11M
Enterprise Value
194.59M
1-Year Change
30.91%
Ranking
Category
Stock Price
$2.31

Market Cap Chart

Since August 12, 2004, Stereotaxis's market cap has increased from $183.10M to $199.11M, an increase of 8.75%. That is a compound annual growth rate of 0.41%.

History

DateMarket Cap% Change
Dec 20, 2024199.10M40.71%
Dec 29, 2023141.50M-8.65%
Dec 30, 2022154.90M-66.50%
Dec 31, 2021462.40M23.27%
Dec 31, 2020375.10M6.26%
Dec 31, 2019353.00M474.92%
Dec 31, 201861.40M237.36%
Dec 29, 201718.20M28.17%
Dec 30, 201614.20M-10.69%
Dec 31, 201515.90M-47.52%
Dec 31, 201430.30M-47.49%
Dec 31, 201357.70M215.30%
Dec 31, 201218.30M-55.90%
Dec 30, 201141.50M-76.45%
Dec 31, 2010176.20M-2.22%
Dec 31, 2009180.20M19.97%
Dec 31, 2008150.20M-63.64%
Dec 31, 2007413.10M27.11%
Dec 29, 2006325.00M49.56%
Dec 30, 2005217.30M991.96%
Dec 31, 200419.90M-89.13%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Compass Therapeutics 195.38M
Biodesix 194.93M
EUDA Health Holdings 191.95M
Fate Therapeutics 191.91M
Verastem 189.60M
Cybin 189.21M
Amarin Corporation 186.09M
XBiotech 185.64M
Market Cap Rankings